SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Richard Levine—Alamy Stock Pho Alamy Stock Photo

100

Johnson & Johnson

JNJ

U.S.

The 132-year-old company, which specializes in pharmaceuticals, consumer health care, and medical devices, sells a wide array of health and beauty products including the Johnson’s Baby line, Neutrogena, Listerine, Band Aids, Tylenol, and Motrin. The company has been at the center of lawsuits concerning products that contain talc and their possible link to ovarian cancer and lung-related cancers, and has also been sued in connection with the U.S. opioid epidemic. But even amid legal conflicts and competition and pricing pressures in the industry, the company saw domestic sales increase 5.4% and international sales increase 7.4% in 2017. The company raised its sales outlook for 2018 due to the high performance of its pharmaceutical business, particularly cancer drugs.

Looking for leads, investment insights, or competitive intelligence?

CEO

Alex Gorsky

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New Brunswick, N.J.

Years on Global 500 List

18

Employees

134,000

Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$76,4506.3%
Profits ($M)$1,300.0-92.1%
Assets ($M)$157,303
Total Stockholder Equity ($M)$60,160
Profit Ratios
Profit as % of Revenues1.7%
Profits as % of Assets0.8%
Profits as % of Stockholder Equity2.2%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Johnson & Johnson

J&J CEO's West Point Lesson: Great Leaders Know How to Listen

CEO Alex Gorsky says his West Point education impacted how he leads at Johnson and Johnson.

Read More →
Xarelto to Become First Prescription Drug With TV Ads That Includes Pricing

There has been government pressure to push all drugmakers into showing prices in ads.

Read More →
Johnson & Johnson and Bayer Settle Xarelto Lawsuits for $775 Million

The drug companies agreed to settle more than 25,000 lawsuits in the U.S. and admit no liability.

Read More →
Jury Awards $29 Million in Latest Johnson & Johnson Cancer-Causing Baby Powder Lawsuit

The lawsuit alleged that the company's talcum-based baby powder contained asbestos.

Read More →